Drug interactions
Deferasirox + Lovotibeglogene autotemcel
Severity: Major
Deferasirox and Lovotibeglogene autotemcel: major interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Deferasirox may cause cytopenias and is advised to be stopped before mobilization and conditioning for gene therapy. Overlap may impair stem cell collection and engraftment.
What this interaction means in plain words
Deferasirox and Lovotibeglogene autotemcel can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Why it happens
Potential myelosuppressive effect of deferasirox interfering with mobilization and engraftment.
What to do
Discontinue deferasirox at least 7 days before mobilization and conditioning. Use phlebotomy or a non-myelosuppressive chelator if iron removal is needed.
What to ask your pharmacist
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Deferasirox and Lovotibeglogene autotemcel, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Deferasirox
Frequently asked questions
Can I take Deferasirox with Lovotibeglogene autotemcel?
MediHelp rates the interaction as major. Deferasirox and Lovotibeglogene autotemcel can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Deferasirox may cause cytopenias and is advised to be stopped before mobilization and conditioning for gene therapy. Overlap may impair stem cell collection and engraftment.
How serious is the interaction between Deferasirox and Lovotibeglogene autotemcel?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Discontinue deferasirox at least 7 days before mobilization and conditioning. Use phlebotomy or a non-myelosuppressive chelator if iron removal is needed.
What other medicines interact with Deferasirox?
MediHelp also lists interactions of Deferasirox with, for example, Acetylsalicylic acid, Alosetron, Aluminum hydroxide. The full list is on the Deferasirox page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
